Novavax delays Covid vaccine authorization request
Cell reprogramming could aid spinal cord injury recovery
11 May 2021Supporting teams through the pandemic: nephrologist Reza Motazed
11 May 2021Novavax delays Covid vaccine authorization request
US biotech firm Novavax on Monday said it had delayed plans to seek authorization for its Covid vaccine candidate, a setback for developing countries hoping the injection would soon be available.
